Status:
TERMINATED
First in Man Study With SLV341
Lead Sponsor:
Solvay Pharmaceuticals
Collaborating Sponsors:
Quintiles, Inc.
Conditions:
Diabetes
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
First in man study with single and multiple rising doses with SLV341
Eligibility Criteria
Inclusion
- Inclusion Criteria healthy Exclusion Criteria not healthy
Exclusion
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT00887445
Start Date
July 1 2008
End Date
May 1 2009
Last Update
April 28 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
S341.1.001 Site #
London, United Kingdom